High Sensitive Troponin I – Risk Stratification for Future Cardiac Events

High Sensitive Troponin I – Risk Stratification for Future Cardiac Events

RISK-STRATIFICATION OF THE APPARENTLY HEALTHY POPULATION USING CURRENT TOOLS

• Risk Stratification is a tool to help identify and predict patients at high-risk or potentially at high-risk of heart attacks, heart failure or death, and prioritizing their care to help prevent unfavorable outcomes.
• Current risk-stratification tools like Framingham, Euroscore and Lipid profile are not cardiac specific and can be heavily influenced by age. 

RISK-STRATIFICATION OF THE APPARENTLY HEALTHY POPULATION USING ALINITY HIGH SENSITIVE TROPONIN-I

• The cardiac specific biomarker that aids in predicting future cardiac events using the unmatched power of cardiac specificity for a blood test that can be added to existing wellness check offerings. 
• In conjunction with clinical and diagnostic findings, aids in earlier identification and intervention in higher risk patients to prevent cardiac events.
• Compared to existing risk-stratification tools, provides greater accuracy in identifying lower risk patients, which may avoid unnecessary investigations, treatments and potential side effects.
• Through early identification and appropriate categorization of at-risk patients,7 has the potential to reduce the growing cost burden to the healthcare system. 
• Resistant to biotin interference.

THE FOLLOWING CUT-OFF USED TO AID IN STRATIFYING THE RISK OF CARDIOVASCULAR DISEASE IN ASYMPTOMATIC INDIVIDUALS: 

Risk

Male (ng/L)

Female (ng/L)

Low

<6

<4

Moderate

6 – 12

4 – 10

Elevated

>12

>10

Asymptomatic individuals with elevated troponin levels are associated with a higher risk of developing cardiovascular related diseases in the future.